In vitro production of collagen by synovial fibroblasts from D-penicillamine-treated arthritic rabbits.
In order to get further insight into the mechanism of D-penicillamine action on synovial tissue collagen synthesis, fibroblasts derived from drug-treated arthritic rabbits were cultured and labelled with radioactive proline. No evident correlation was found between the amount of newly synthesized collagen and the previous treatment of animals. In contrast, the prolyl-hydroxylase activity was reduced in cells from rabbits receiving D-penicillamine. This finding suggests that culture conditions may influence the collagen-synthesizing potentiality of the synovial fibroblasts without changing the level of enzyme activity. Therefore, the prolyl-hydroxylase activity could be considered here as a more reliable reflection of the in vivo situation. The ratio of type III to type I procollagens, as estimated by DEAE-cellulose chromatography, showed a rise in cultures from D-penicillamine-treated rabbits as compared to controls. This result indicates that long-term administration of the drug may alter the collagen composition of synovial tissue matrix in rheumatoid arthritis. The question remains, however, whether this alteration contributes to the beneficial effect of the drug.
D000818:Animals; D001168:Arthritis / Q000188:drug therapy / Q000378:metabolism*; D003094:Collagen / Q000096:biosynthesis*; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D010396:Penicillamine / Q000494:pharmacology*; D011347:Procollagen / Q000096:biosynthesis; D011393:Procollagen-Proline Dioxygenase / Q000378:metabolism; D011817:Rabbits; D013583:Synovial Membrane / Q000187:drug effects / Q000378:metabolism*
D011347:Procollagen; D003094:Collagen; D011393:Procollagen-Proline Dioxygenase; D010396:Penicillamine